ALFA Finder
17:47 IST
BSE
Financial Results
Hemo Organic Q1 FY27 Results: Net Loss of ₹0.1 Cr
Hemo Organic Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Hemo Organic Ltd
- Share price
- ₹20.99
- Market cap
- ₹14.41 Cr
- Revenue (annual)
- ₹0.93 Cr
- Net profit (annual)
- ₹-0.78 Cr
- P/E (TTM)
- -19.7×Sector 46.8×
- Promoter holding
- 2.50%-14.35% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Selling (Off-Market) 6Other Announcement 5Management Change 5Financial Results 5Board Meeting Date 5Capital Structure Change 4Board Meeting Outcome 4Annual General Meeting 2
Time
36 announcements with these filters
18:44 IST
BSE
Board Meeting Date
Hemo Organic Board Meeting Date
Hemo Organic scheduled a board meeting for July 15, 2026. The board will consider un-audited financial results for the June quarter.
18:36 IST
BSE
Financial Results
Hemo Organic Financial Results
Hemo Organic Limited reported an annual total income of ₹0.93 Crore for FY26. The auditor issued a modified opinion due to missing balance confirmations for key accounts.
- Value
- ₹0.93 Cr
17:59 IST
BSE
Financial Results
Hemo Organic Q4 FY26 Results: Net Loss of ₹0.5 Cr
Hemo Organic Ltd reported revenue from operations of ₹0.9 Cr (-62.5% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.5 Cr
17:58 IST
BSE
Financial Results
Hemo Organic Financial Results
Hemo Organic Limited reported audited financial results for the year ended March 31, 2026. The company recorded a net loss of ₹77.81 lakhs for the period.
17:43 IST
BSE
Board Meeting Date
Hemo Organic Board Meeting Date
Hemo Organic Limited scheduled a board meeting on May 29, 2026. Directors will consider and approve audited financial results for the quarter and year ended March 2026.